TVM Capital Healthcare has invested in US-based Human Longevity, focusing on precision medicine and healthy aging. The undisclosed deal aims to support Human Longevity's expansion in the US, Saudi Arabia, and South-East Asia, aligning with Saudi Arabia's healthcare strategy shift towards preventive medicine.